Sign in
4

Changes in Ownership

Evofem Biosciences, Inc. Filed Acc 0001618835-19-000141

Chief Commercial Officer gave up 13,257 shares (to pay taxes)

  • Chief Commercial Officer acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Barrans Russell · Chief Commercial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-07-08 Grant or award : show line 1 in the form +150,000 230,416 D
2019-07-08 Shares withheld for taxes : show line 2 in the form −13,257 $4.99 $66,152 217,159 D
Loading xslF345X03/wf-form4_156279996204676.xml…